Search
for
Sort by
Research 541–570 of 1000+
- Testosterone Reduces Knee Passive Range of Motion and Expression of Relaxin Receptor Isoforms via 5α-Dihydrotestosterone and Androgen Receptor Binding
- Fluoride exposure and pubertal development in children living in Mexico City
- Polycystic Ovary Syndrome (PCOS) and Fertility
- Are sex hormones promising candidates to explain sex disparities in the COVID-19 pandemic?
- Dermatological problems of the puberty
- Ovarian sex steroid receptors and sex hormones in androgenized rats
- Hyperandrogenism and menstrual imbalance are the best predictors of metformin response in PCOS patients
- Incredible Combination of Lifestyle Modification and Herbal Remedies for Polycystic Ovarian Syndrome Management
- Exploring obesity-related endocrine disorders beyond diabetes: a narrative review
- The emerging roles of N6-methyladenosine (m6A) deregulation in polycystic ovary syndrome
- Adult Male Hypogonadism: A Laboratory Medicine Perspective on Its Diagnosis and Management
- Differences in male and female pattern hair loss based on androgens, estrogen, iron, vitamin D, lipid metabolism, and genetic regulation
- Gene expression of FOXA1 and CCL2 in different phenotypes of infertile women with polycystic ovarian syndrome
- A New Role of Non-Sex Hormone in the Pathogenesis of Female Pattern Hair Loss
- LH Induces Murine Hair Loss through TRPC-Medicated Cell Aging Responses: Implications for Female Pattern Hair Loss Pathogenesis
- Lifestyle changes and Nutrition in Polycystic Ovarian Disorder: A Holistic Review
- Bioinformatic network analysis on the molecular interactions between Parkinson’s disease, alpha-synuclein, and infertility condition
- Congenital Adrenal Hyperplasia
- Changes in bone mineral density in women with early-onset androgenetik alopecia and their correlations with hair-loss stages: a cross-sectional study
- Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome.
- Clinical and Hormonal Effects of Chronic Gonadotropin Releasing Hormone Agonist Treatment in Polycystic Ovarian Disease*
- Three-Month Treatment With a Long-Acting Gonadotropin-Releasing Hormone Agonist of Patients With Benign Prostatic Hyperplasia: Effects on Tissue Androgen Concentration, 5<i>α</i>-Reductase Activity and Androgen Receptor Content*
- Treatment of Hirsutism with a Gonadotropin-Releasing Hormone Agonist (Nafarelin)∗
- Comparison of a gonadotropin-releasing hormone agonist and a low dose oral contraceptive given alone or together in the treatment of hirsutism.
- 17-Hydroxyprogesterone Responses to Gonadotropin-Releasing Hormone Disclose Distinct Phenotypes of Functional Ovarian Hyperandrogenism and Polycystic Ovary Syndrome
- Gonadotropin-Releasing Hormone Agonist Treatment in Postmenopausal Women with Hyperandrogenism of Ovarian Origin
- Gonadotropin releasing hormone agonist (nafarelin) test to differentiate gonadotropin deficiency from constitutionally delayed puberty in teen-age boys--a clinical research center study.
- Effects of finasteride, a 5 alpha-reductase inhibitor, on circulating androgens and gonadotropin secretion in hirsute women.
- Long-Term Suppression of Testosterone After Treatment with a Gonadotropin-Releasing Hormone Agonist in a Woman with a Presumed Testosterone Secreting Ovarian Tumor
- Treatment of hirsutism with a gonadotropin-releasing hormone agonist and estrogen replacement therapy